Lindsay Beyerstein at Majikthise posts about Bill Frist’s call to end direct to consumer (DTC) prescription drug advertisements, and the political implications of his doing so. Beyerstein concludes that “Frist’s defection may say more about the political fortunes of movement conservatism than about Frist’s own prospects.”
For the record, I agree with Frist’s view (see the Boston Globe article) that “such advertising …drives a wedge between doctors and patients and increases prescription drug costs.” But, is this just political maneuvering? Or might something meaningful come about from Frist’s stance? Even if it doesn’t actually lower drug prices, would removing the “wedge” be better for patients health?